| Serial Number | 87222044 |
| Word Mark | BASILEA PHARMACEUTICA |
| Filing Date | Tuesday, November 1, 2016 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 4, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 3, 2017 |
| Disclaimer with Predetermined Text | "PHARMACEUTICA" |
| Goods and Services | Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use |
| Goods and Services | Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use (Class 001); Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents |
| Goods and Services | Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 4, 2016 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 4, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 4, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Basilea Pharmaceutica International Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Basel 4058 CH |
| Party Name | Basilea Pharmaceutica International Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | 4058 Basel CH |
| Event Date | Event Description |
| Monday, January 4, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, January 4, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, May 13, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 12, 2020 | EXTENSION 5 GRANTED |
| Thursday, April 30, 2020 | EXTENSION 5 FILED |
| Thursday, April 30, 2020 | TEAS EXTENSION RECEIVED |
| Saturday, October 26, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 24, 2019 | EXTENSION 4 GRANTED |
| Thursday, October 24, 2019 | EXTENSION 4 FILED |
| Thursday, October 24, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, May 29, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 27, 2019 | EXTENSION 3 GRANTED |
| Monday, May 27, 2019 | EXTENSION 3 FILED |
| Monday, May 27, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, May 22, 2019 | CORRECTED NOA E-MAILED |
| Tuesday, May 21, 2019 | DIVISIONAL PROCESSING COMPLETE |
| Friday, May 3, 2019 | DIVISIONAL REQUEST RECEIVED |
| Monday, May 20, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, May 3, 2019 | TEAS REQUEST TO DIVIDE RECEIVED |
| Friday, November 2, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 31, 2018 | EXTENSION 2 GRANTED |
| Wednesday, October 31, 2018 | EXTENSION 2 FILED |
| Wednesday, October 31, 2018 | TEAS EXTENSION RECEIVED |
| Friday, May 11, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 9, 2018 | EXTENSION 1 GRANTED |
| Wednesday, May 9, 2018 | EXTENSION 1 FILED |
| Wednesday, May 9, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, November 28, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 3, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 3, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 13, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 25, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 11, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 10, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 10, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 10, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 10, 2017 | NON-FINAL ACTION E-MAILED |
| Friday, February 10, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 8, 2017 | ASSIGNED TO EXAMINER |
| Friday, November 4, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, November 4, 2016 | NEW APPLICATION ENTERED IN TRAM |